Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GIS vs GSK✓SelectedUSD · GSKGIS vs GSK performance historyLatest closeAs of+2.68%11/16
Stock and ETF performance explorer

GIS vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+1,389.8%
GSK return
+1,741.1%
Excess return
-351.3%
Maximum drawdown
-59.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+2.7%-0.1%+2.8%+2.7%
7D+1.0%-1.3%+2.3%+1.3%
30D+6.4%+2.7%+3.6%+5.7%
3M-8.4%+2.7%-11.1%-9.0%
6M+10.7%+3.3%+7.4%+9.8%
YTD-19.0%+6.5%-25.4%-20.5%
1Y-20.5%+10.7%-31.2%-22.8%
3Y-37.2%+64.4%-101.6%-44.9%
5Y-31.6%+46.7%-78.3%-38.9%
10Y-15.1%+109.4%-124.5%-30.7%
All+1,389.8%+1,741.1%-351.3%+512.3%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling